Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Stabilization of β-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia

Abstract

The present study documents that stabilization of β-catenin is sufficient to induce lesions reminiscent of prostate intraepithelial neoplasia (PIN). Such lesions were present in all compound mutant mice and all prostate acini expressing stabilized β-catenin. High grade PIN-like lesions resembling early human prostate cancer were detected as early as 10 weeks of age. Surprisingly, stabilization of β-catenin in other secretory epithelia including salivary, preputial, harderian, and mammary glands induced extensive squamous metaplasia and keratinization associated with terminal differentiation of the target cells, but failed to cause neoplastic transformation. Epidermal hyperplasia, hair follicle cysts, and odontomas were also observed. The prostatic lesions exhibited upregulation of c-myc, increased rate of cellular proliferation, loss of the Na-K-Cl co-transporter NKCC1, and expression of androgen receptor. Basal cell markers such as p63 and keratin 5 were not expressed by the masses of PIN-like lesions, but were present in small foci of proliferating β-catenin expressing basal cells. Our observations indicate that β-catenin stabilization is a crucial event for the initiation of PIN-like lesions, but induces squamous metaplasia rather than tumorigenesis in secretory epithelia other than the prostate.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Abate-Shen C, Shen MM . 2000 Genes Dev. 14: 2410–2434

  • Bienz M, Clevers H . 2000 Cell 103: 311–320

  • Brewster SF, Browne S, Brown KW . 1994 J. Urol. 151: 1073–1077

  • Bussemakers MJ, Van Bokhoven A, Tomita K, Jansen CF, Schalken JA . 2000 Int. J. Cancer 85: 446–450

  • Chesire DR, Ewing CM, Sauvageot J, Bova GS, Isaacs WB . 2000 Prostate 45: 323–334

  • Davies G, Jiang WG, Mason MD . 2000 J. Urol. 163: 985–992

  • Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, Renault B, Breukel C, Alt E, Lipkin M, Khan PM, Kucherlapati R . 1994 Proc. Natl. Acad. Sci. USA 91: 8969–8973

  • Gat U, DasGupta R, Degenstein L, Fuchs E . 1998 Cell 95: 605–614

  • Gottardi CJ, Gumbiner BM . 2001 Current Biol. 11: R792–R794

  • Gottardi CJ, Wong E, Gumbiner BM . 2001 J. Cell. Biol. 153: 1049–1060

  • Gounari F, Aifantis I, Khazaie K, Hoeflinger S, Harada N, Taketo MM, von Boehmer H . 2001 Nat. Immunol. 2: 863–869

  • Haas M, Forbush III B . 1998 J. Bioenerg. Biomembr. 30: 161–172

  • Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM . 1999 EMBO J. 18: 5931–5942

  • Hayward SW, Baskin LS, Haughney PC, Cunha AR, Foster BA, Dahiya R, Prins GS, Cunha GR . 1996 Acta Anat. 155: 81–93

  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW . 1998 Science 281: 1509–1512

  • Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P . 2001 J. Cell. Biol. 153: 555–568

  • Iozzo RV, Eichstetter I, Danielson KG . 1995 Cancer Res. 55: 3495–3499

  • Khazaie K, Prifti S, Beckhove P, Griesbach A, Russell S, Collins M, Schirrmacher V . 1994 Proc. Natl. Acad. Sci. USA 91: 7430–7434

  • Kinzler KW, Vogelstein B . 1996 Cell 87: 159–170

  • Kurita T, Wang YZ, Donjacour AA, Zhao C, Lydon JP, O'Malley BW, Isaacs JT, Dahiya R, Cunha GR . 2001 Cell Death Differ. 8: 192–200

  • Lau W, Clevers H . 2001 Nat. Genet. 28: 3–4

  • Li Y, Hively WP, Varmus HE . 2000 Oncogene 19: 1002–1009

  • Luongo C, Moser AR, Gledhill S, Dove WF . 1994 Cancer Res. 54: 5947–5952

  • Magi-Galluzzi C, Xu X, Hlatky L, Hahnfeldt P, Kaplan I, Hsiao P, Chang C, Loda M . 1997 Mod. Pathol. 10: 839–845

  • McNeal JE, Bostwick DG . 1986 Hum. Pathol. 17: 64–71

  • Miyoshi K, Cui Y, Riedlinger G, Lehoczky J, Zon L, Oka T, Dewar K, Hennighausen L . 2001 Genomics 71: 150–155

  • Moore-Hoon ML, Turner RJ . 1998 Biochim. Biophys. Acta. 1373: 261–269

  • Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW . 1997 Science 275: 1787–1790

  • Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC . 2002 J. Biol. Chem. 20: 20–

  • Phillips SM, Morton DG, Lee SJ, Wallace DM, Neoptolemos JP . 1994 Br. J. Urol. 73: 390–395

  • Rashid MG, Sanda MG, Vallorosi CJ, Rios-Doria J, Rubin MA, Day ML . 2001 Cancer Res. 61: 489–492

  • Reya T, Morrison SJ, Clarke MF, Weissman IL . 2001 Nature 414: 105–111

  • Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, Kanamaru R, Kanegae Y, Saito I, Nakamura Y, Shiba K, Noda T . 1997 Science 278: 120–123

  • Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, Yang A, Montironi R, McKeon F, Loda M . 2000 Am. J. Pathol. 157: 1769–1775

  • Soriano P . 1999 Nat. Genet. 21: 70–71

  • Sparks AB, Morin PJ, Vogelstein B, Kinzler KW . 1998 Cancer Res. 58: 1130–1134

  • Stanbrough M, Leav I, Kwan PW, Bubley GJ, Balk SP . 2001 Proc. Natl. Acad. Sci. USA 98: 10823–10828

  • Sundberg JP . 2000 Colon Cancer Study Section Sundberg JP (ed) The Jackson Laborator

    Google Scholar 

  • Suzuki H, Aida S, Akimoto S, Igarashi T, Yatani R, Shimazaki J . 1994 Jpn. J. Cancer Res. 85: 847–852

  • Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM . 1998 Cell 92: 645–656

  • Tetsu O, McCormick F . 1999 Nature 398: 422–426

  • Truica CI, Byers S, Gelmann EP . 2000 Cancer Res. 60: 4709–4713

  • Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E . 2001 Cell 104: 605–617

  • Voeller HJ, Truica CI, Gelmann EP . 1998 Cancer Res. 58: 2520–2523

  • Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L . 1997 Nucleic Acids Res. 25: 4323–4330

  • Watanabe M, Kakiuchi H, Kato H, Shiraishi T, Yatani R, Sugimura T, Nagao M . 1996 Jpn. J. Clin. Oncol. 26: 77–81

  • Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z . 2002 J. Biol. Chem. 15: 15–

Download references

Acknowledgements

K Khazaie was supported by the National Colorectal Research Alliance, Dana Farber Cancer Institute, and the Harvard Cancer Center. M Taketo was supported by the Organization for Pharmaceutical Safety and Research (OPSR) and the Ministry of Education, Science, Sports and Culture (MESSC) of Japan. We thank N Harada for the construction of the Catnb +/lox(ex3) mice. K Khazaie is obliged to Robert Mayer, Glenn Dranoff, and Ramesh Shivdasani for their support and encouragement. This work would have not been possible without the advice of Massimo Loda, Lothar Hennighausen, Keiko Miyoshi and Jonathan M Shillingford. Li Zhang and James Dilks are acknowledged for excellent histological service. Eric Smith is acknowledged for expert assistance with recording and presentation of images.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Khashayarsha Khazaie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gounari, F., Signoretti, S., Bronson, R. et al. Stabilization of β-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia. Oncogene 21, 4099–4107 (2002). https://doi.org/10.1038/sj.onc.1205562

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205562

Keywords

This article is cited by

Search

Quick links